Clinical Trials Directory

Trials / Completed

CompletedNCT00996697

Differential Trough Effects of 'Triple Therapy' on Pulmonary Function in Chronic Obstructive Pulmonary Disease (COPD)

A Proof Of Concept Study To Evaluate Tiotropium as Add-on Therapy to Inhaled Budesonide/Formoterol Combination in COPD

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
23 (actual)
Sponsor
Brian J Lipworth · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

Different medications are often used in combination for the condition COPD (chronic obstructive pulmonary disease). Some medicines act by opening the airways (bronchodilators) and some act as anti-inflammatories (steroids). More recently an approach of using a combination inhaler (containing a steroid and a long-acting bronchodilator) at the same time as a long acting bronchodilator of a different group of medicines (anti-cholinergics inhalers) has been used. This approach is sometimes called 'triple therapy'. Studies which have looked at these combinations usually use only standard blowing tests (spirometry) to test these medicines and focus on the effects of the medicines at their highest (peak) levels. It is some ways more relevant to study these medicines towards to end of the dose period (trough)- just before the next dose. This is when there is less medicine in the system, and differences in drug effects are more obvious. There are also more detailed breathing tests than spirometry which get a more detailed picture of the way the lungs respond to bronchodilator medicines. The investigators have studied 'triple therapy' in COPD, by measuring the effects at the end of the dosing interval (trough) using a range of detailed respiratory tests.

Conditions

Interventions

TypeNameDescription
DRUGBudesonide/formoterol and tiotropiumSymbicort 200/2, 2puff bid plus tiotropium 18mcg/day
DRUGBudesonide/formoterol and placeboSymbicort 200/6 2puff bid and placebo

Timeline

Start date
2006-10-01
Primary completion
2008-09-01
Completion
2008-09-01
First posted
2009-10-16
Last updated
2019-04-12

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00996697. Inclusion in this directory is not an endorsement.